PURCHASE AGREEMENT ------------------Purchase Agreement • March 17th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
EXHIBIT 4.4 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN...Boston Life Sciences Inc /De • August 4th, 2000 • Pharmaceutical preparations • Delaware
EXHIBIT 10.5 REGISTRATION RIGHTS AGREEMENT -----------------------------Registration Rights Agreement • September 27th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
ANDLicense Agreement • January 4th, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
EXHIBIT 4.5 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN...Boston Life Sciences Inc /De • March 29th, 1999 • Pharmaceutical preparations • Delaware
Form of Warrant to Purchase --------------------------- Common Stock ------------Boston Life Sciences Inc /De • March 12th, 2002 • Pharmaceutical preparations • Massachusetts
RECITALSNote Purchase Agreement • May 3rd, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
Exhibit 10.54 BOSTON LIFE SCIENCES, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2005 STOCK INCENTIVE PLAN 1. Grant of Option. This agreement evidences the grant by Boston Life Sciences, Inc., a Delaware corporation (the "Company"), on [ ],...Incentive Stock Option Agreement • March 31st, 2006 • Boston Life Sciences Inc /De • Pharmaceutical preparations
WITNESSETH ----------Registration Rights Agreement • March 12th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations
EXHIBIT 10.8 EXCHANGE AGREEMENT EXCHANGE AGREEMENT (this "AGREEMENT"), dated as of February ____, 1999, by and among Boston Life Sciences, Inc., a Delaware corporation (the "COMPANY"), and ________________________ _____________________________ (the...Exchange Agreement • March 17th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
WHEREAS, the Company and the Purchasers are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Rule 506 under Regulation D as promulgated by the United States Securities and Exchange...Securities Purchase Agreement • September 27th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
Exhibit 99.6 AMENDMENT NO. 3 TO RIGHTS AGREEMENT This AMENDMENT NO. 3 made as of the 12 day of March, 2003, between Boston Life Sciences, Inc., a Delaware corporation (the "Company"), and Continental Stock Transfer & Trust Company, a Delaware...Rights Agreement • March 13th, 2003 • Boston Life Sciences Inc /De • Pharmaceutical preparations
andRights Agreement • September 13th, 2001 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
RECITALSPurchase Agreement • June 9th, 2000 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
Exhibit 10.54 Boston Life Sciences, Inc. Nonstatutory Stock Option Agreement 1. Grant of Option. This agreement (hereinafter, the "Agreement") evidences the grant by Boston Life Sciences, Inc., a Delaware corporation (the "Company"), on JULY 18, 2005...Stock Option Agreement • April 2nd, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Delaware
SECTION 1. ----------Boston Life Sciences Inc /De • March 17th, 1999 • Pharmaceutical preparations • New York
Exhibit 4.1 FORM OF CLASS A WARRANT NEITHER THIS WARRANT NOR THE SECURITIES FOR WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON EXEMPTIONS...Boston Life Sciences Inc /De • August 14th, 2002 • Pharmaceutical preparations • New York
EXHIBIT 10.4 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (the "Agreement") is made and entered into as of this 1st day of June, 2000 by and between Boston Life Sciences, Inc., a Delaware corporation...Registration Rights Agreement • June 9th, 2000 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
Warrant for the Purchase of Shares of Common StockBoston Life Sciences Inc /De • July 30th, 2002 • Pharmaceutical preparations • Massachusetts
RECITALSEmployment Agreement • July 17th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
Exhibit 10.52 BOSTON LIFE SCIENCES, INC. NONSTATUTORY STOCK OPTION AGREEMENT GRANTED UNDER 2005 STOCK INCENTIVE PLAN 1. Grant of Option. This agreement evidences the grant by Boston Life Sciences, Inc., a Delaware corporation (the "Company"), on...Nonstatutory Stock Option Agreement • March 31st, 2006 • Boston Life Sciences Inc /De • Pharmaceutical preparations
EXCLUSIVE LICENSE AGREEMENT BETWEENExclusive License Agreement • August 14th, 2006 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
Exhibit 99.4 SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT This SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT (the "Addendum") is made and entered into as of March 12, 2003, by and among Boston Life Sciences, Inc., a Delaware corporation (the...Registration Rights Agreement • March 13th, 2003 • Boston Life Sciences Inc /De • Pharmaceutical preparations
This SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT (the "Addendum") is made and entered into as of March 12, 2003, by and among Boston Life Sciences, Inc., a Delaware corporation (the "Company") and each of the purchasers set forth on the execution page hereof (the "Purchasers"). This Addendum supplements that certain Registration Rights Agreement, dated as of July 25, 2002, by and among the Company and the Initial Holders (as defined therein), as supplemented by the First Addendum thereto dated as of November 22, 2002 (the "Registration Rights Agreement"). Capitalized terms not defined herein shall have the meanings given to them in the Registration Rights Agreement.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 16th, 2003 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).
EXHIBIT 99.2 OMNIBUS AGREEMENT II OMNIBUS AGREEMENT II (this "Agreement"), dated as of May 16, 2002, by and between BOSTON LIFE SCIENCES, INC., a Delaware corporation (the "Company"), and BROWN SIMPSON PARTNERS I, LTD., a Cayman Islands company (the...Omnibus Agreement • November 15th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
Exhibit 99.4 FIRST ADDENDUM TO REGISTRATION RIGHTS AGREEMENT This FIRST ADDENDUM TO REGISTRATION RIGHTS AGREEMENT (the "Addendum") is made and entered into as of November 22, 2002, by and among Boston Life Sciences, Inc., a Delaware corporation (the...Registration Rights Agreement • November 25th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations
EXHIBIT 10.2 AMENDED AND RESTATED PROMISSORY NOTEBoston Life Sciences Inc /De • February 13th, 2007 • Pharmaceutical preparations • Massachusetts
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of BOSTON LIFE SCIENCES, INC.Boston Life Sciences Inc /De • December 16th, 2003 • Pharmaceutical preparations • New York
THIS IS TO CERTIFY THAT , or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from Boston Life Sciences, Inc., a Delaware corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $1.49 per share, all on and subject to the terms and conditions hereinafter set forth.
EXHIBIT 10.50 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is made and entered into as of March 31, 2006 and is effective as of January 1, 2006 (the "Effective Date"), by and between BOSTON LIFE SCIENCES, INC., a Delaware corporation...Employment Agreement • March 31st, 2006 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Delaware
AMENDMENT TO LICENSE AGREEMENT BETWEEN ORGANIX, INC. AND BOSTON LIFE SCIENCES, INC., EFFECTIVE AS OF JULY 1, 2000 RE: HARVARD CASE NO: 1382 (THE "LICENSE")License Agreement • May 15th, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations
Exhibit 10.15 THIS AGREEMENT made in duplicate as of this 9th day of August, 2000. BETWEEN:Confidential Treatment Requested • August 9th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Ontario
Exhibit 10.53 Boston Life Sciences, Inc. Nonstatutory Stock Option Agreement 1. Grant of Option. This agreement (hereinafter, the "Agreement") evidences the grant by Boston Life Sciences, Inc., a Delaware corporation (the "Company"), on NOVEMBER 18,...Boston Life Sciences Inc /De • April 2nd, 2007 • Pharmaceutical preparations • Delaware
Exhibit 99.1 FORM OF SUBSCRIPTION AGREEMENT Boston Life Sciences, Inc. 137 Newbury Street Boston, Massachusetts 02116 Ladies and Gentlemen: 1. Subscription. ------------ (a) The undersigned ("Subscriber"), intending to be legally bound, hereby...Form of Subscription Agreement • March 12th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
AMENDMENT TO LICENSE AGREEMENT BETWEEN THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE AND BOSTON LIFE SCIENCES, INC., EFFECTIVE AS OF OCTOBER 15, 1996 RE: HARVARD CASE NO: 1194-95 (THE "LICENSE")License Agreement • May 15th, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.
